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ABSTRACT
Lymphoid specific helicase (Lsh) belongs to the
family of SNF2/helicases. Disruption of Lsh leads
to developmental growth retardation and premature
aging in mice. However, the specific effect of Lsh
on human cellular senescence remains unknown.
Herein, we report that Lsh overexpression delays
cell senescence by silencing p16
INK4a in human
fibroblasts. The patterns of p16
INK4a and Lsh expres-
sion during cell senescence present the inverse
correlation. We also find that Lsh requires histone
deacetylase (HDAC) activity to repress p16
INK4a and
treatment with trichostatin A (TSA) is sufficient
to block the repressor effect of Lsh. Moreover, over-
expression of Lsh is correlated with deacetylation of
histone H3 at the p16 promoter, and TSA treatment
in Lsh-expressing cells reverses the acetylation
status of histones. Additionally, we demonstrate
an interaction between Lsh, histone deacetylase
1 (HDAC1) and HDAC2 in vivo. Furthermore, we
demonstrate that Lsh interacts in vivo with the p16
promoter and recruits HDAC1. Our data suggest
that Lsh represses endogenous p16
INK4a expression
by recruiting HDAC to establish a repressive chro-
matin structure at the p16
INK4a promoter, which in
turn delays cell senescence.
INTRODUCTION
Senescence is a state during which cells lose the ability
to proliferate that is accompanied by speciﬁc changes
in cellular morphology and gene expression. During the
process of cell senescence, senescence-associated beta-
galactosidase (SA-b-gal) is activated, the cell cycle is irre-
versibly arrested at the G1 phase, senescence-associated
hetero-chromatic foci form and expression of the cyclin-
dependent kinase inhibitor (CDKI) increases (1,2).
Lymphoid speciﬁc helicase (Lsh), also termed as prolif-
eration associated SNF-2-like gene (PASG), was origi-
nally found to be expressed only in lymphoid tissue in
adult mice (3). This may have been indicative of the
proliferating nature of lymphoid cells rather than tissue
speciﬁcity, as expression is nearly ubiquitous in the devel-
oping mouse embryo (4,5). Lsh has been shown to be
linked to cell proliferation and premature aging (5,6).
Imperfect maintenance of genome integrity has been pos-
tulated to be an important cause of senescence and pre-
mature aging (7). DNA methylation governs several
distinct processes, including genomic stability and gene
promoter regulation. Errors in replication of DNA-
methylation patterns as observed in mutant Lsh mice
(6,8) may destabilize the genome and activate cellular
self defense mechanisms that prevent cells from entering
S-phase. Altered gene expression, reduced cell prolifera-
tion and abnormal embryonic development are also
consequences. However, other mechanisms may also con-
tribute to the observed senescence phenotypes in Lsh
mutant mice. For example, bmi-1, a transcriptional regu-
lator, may provide an alternative mechanism to DNA
methylation in regulating the expression of p16
INK4a
which plays essential role in establishing a replicative
senescence phenotype (9). Therefore, it can be concluded
that Lsh may play a critical role in aging through multiple
regulatory mechanisms. Herein, we report that Lsh delays
cellular senescence by repressing the senescence-associated
tumor suppression gene, p16
INK4a.
Chromatin remodeling and histone modiﬁcations have
emerged as primary regulatory mechanisms controlling
gene expression. Hyperacetylation of histones H3 or H4
is generally associated with transcriptionally active chro-
matin (10), while the chromatin of inactive regions
is enriched in deacetylated histones H3 and H4. The
acetylation status of histones at speciﬁc DNA-regulatory
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transferases or histone deacetylase (HDAC) activities.
Lsh is a member of the SNF2 family of helicases that is
involved in chromatin remodeling (3,11). As described
previously, histone acetylation is a marker for transcrip-
tional activation. Huang et al. (12) reported that Lsh
regulates histone acetylation at repetitive elements.
Furthermore, it has been reported that histone H3
acetylation was enhanced in Lsh
 /  mouse embryonic
ﬁbroblasts (MEFs) at the promoters of genes whose
expression levels were aﬀected by the absence of Lsh,
including HoxA6 and HoxA7 (13). Here, we found that
Lsh-mediated p16
INK4a repression was not due to CpG
methylation at promoter, which is in agreement with a
previous report (6), but, is involved in HDAC-mediated
histone deacetylation. We report that the endogenous p16
promoter of Lsh-expressing cells is enriched in deacety-
lated histone H3, and that Lsh-mediated repression is
abolished by treatment with trichostatin A (TSA). Lsh
interacts directly with the endogenous p16 promoter, as
demonstrated by chromatin immunoprecipitation (ChIP)
assays, and recruits HDAC1. Moreover, in vivo interac-
tions between Lsh, HDAC1 and HDAC2 have also been
reported, suggesting that Lsh may mediate p16 repression
by recruiting a corepressor complex containing HDAC1
and HDAC2 to the p16 promoter.
In this study, we examined the role of Lsh in normal
cellular senescence by assessing the phenotypes associated
with Lsh overexpression and small hairpin RNA
(shRNA)-mediated Lsh silencing. We further identiﬁed
the underlying mechanisms associated with Lsh-mediated
repression of p16.
MATERIALS AND METHODS
Cell line, cell culture and treatments
Human embryonic lung diploid ﬁbroblast 2BS cells
(obtained from the National Institute of Biological
Products, Beijing, China) were previously isolated from
female fetal lung ﬁbroblast tissue and have been fully
characterized (14). 2BS cells are considered to be young
at PD 30 or below and to be fully senescent at PD 55 or
above. Human embryonic lung diploid ﬁbroblast WI-38
cells (ATCC number: CCL75) were obtained from the
Chinese Academy of Sciences (Shanghai, China). WI-38
cells are considered to be young at PD 25 or below and to
be fully senescent at PD 50 or above. All cells were grown
in Dulbecco’s modiﬁed Eagle’s medium (DMEM, GIBCO
BRL, USA) supplemented with 10% heat-inactivated
fetal bovine serum, 100 units/ml penicillin and 100mg/ml
streptomycin at 378Ci n5 %C O 2. Eighty percent conﬂuent
cultures were detached by PBS solution containing 0.25%
trypsin and then split at a ratio of 1:2. TSA (Sigma-
Aldrich, St Louis MO, USA) was dissolved in ethanol
and added to the culture medium at 10ng/ml for 24h.
5-aza-CdR (Sigma-Aldrich) was dissolved in acetic acid/
water (1:1) and added to the culture medium at 1mM for
72h. Fresh medium containing 5-aza-CdR was added
every 24h. A corresponding volume of ethanol or acetic
acid/water was added to untreated control cells.
Generation of plasmids, expression vectors and
stable cell lines
The pcDNA3.1 vector containing Lsh-HA (pcDNA3.1-
Lsh-HA) was a kind gift from Dr David W. Lee (John
Hopkins University).
The short hairpin RNA (shRNA) was designed accord-
ing to the pSuper retro instruction manual (Ambion,
USA). The sequence of the sense strand of Lsh-shRNA
constructed into pSuper GFP neo was 50-GTC CTA CTG
GTC GAC CAA A-30; p16-shRNA constructed into
pSuper puro was 50-AGA ACC AGA GAG GCT CTG
A-30 (15); the template oligonucleotides were inserted into
the BglII and HindIII sites of the pSuper retro vector.
The expression vector pcDNA3.1-Lsh-HA and its
empty vector control were used to transfect young
2BS cells (20 PD) or WI-38 cells (20 PD) using Lipofec-
tamine 2000 (Invitrogen) according to the manufacturer’s
instructions. The shRNA speciﬁc for Lsh and its negative
control were used to infect young 2BS cells using a retro-
viral system. Pools of stable transformants were obtained
by sustained selection with G418 (Life Technologies,
Grand Island, NY, USA). PDs were calculated using the
formula PD=log(n2/n1)/log2, where n1 is the number of
cells seeded and n2 is the number of cells recovered (16).
In experiments presented in Figure 5, young 2BS cells
were co-infected by viruses of pSuper-shRNA-Lsh (neo-
mycin) and pSuper-shRNA-p16 (puromycin). Then
cells were selected with Puromycin (0.7mg/ml) and G418
(200mg/ml), starting 1day after infection.
SA-b-gal and SAHF analysis
For SA-b-gal staining, cells were washed twice in PBS,
ﬁxed for 3–5min at room temperature in 3% formalde-
hyde and washed again with PBS. Then cells were incu-
bated overnight at 378C without CO2 in a freshly prepared
SA-b-gal-staining solution as described (17).
To determine SAHF formation, cells were cultured
directly on glass cover slips and were ﬁxed using 4% par-
aformaldehyde. After washing with PBS, cells were per-
meabilized with 0.2% Triton X-100 in PBS for 10min.
DNA was visualized by DAPI (1mg/ml) staining for
1min, followed by two PBS washes. Cover slips were
mounted in a 90% glycerol PBS solution. Cover slips
were examined using a Leica confocal TCS SP2
microscope.
Cell-cycle analysis
When cells reached 70–80% conﬂuence, they were washed
with PBS, detached with 0.25% trypsin and ﬁxed with
75% ethanol overnight. After treatment with 1mg/ml
RNase A (Sigma) at 378C for 30min, cells were resus-
pended in 0.5ml of PBS and stained with propidium
iodide in the dark for 30min; DNA contents were mea-
sured by ﬂuorescence-activated cell sorting on a FACScan
ﬂow cytometry system (BD Biosciences). The data were
analyzed using CellFiT software. Each experiment was
performed at least three times, and representative data
were shown.
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Cell proliferation was assayed using the MTT method
(18). Cells were plated at a density 2 10
3 cells per well
into 96-well plate and cultured for periods ranging from
1 to 7 days. The medium was replaced at 24-h intervals.
At the indicated times, cells were stained with 20ml MTT
(10mg/ml in PBS; Sigma) for 4h and then dissolved with
DMSO. The optical density at 570nm was determined.
Each curve was performed twice. Each point value was
the mean SD of triplicate points from a representative
experiment (n=3).
Immunoblot analysis
Cells were lysed in modiﬁed Radioimmune Precipitation
Assay (RIPA) Buﬀer (50mM Tris–HCl, pH 7.4, 150mM
NaCl, 1mM EDTA, 0.25% Na–deoxycholate, 1% NP-40,
0.2mM sodium orthovanadate, 1mM NaF) containing a
protease inhibitor cocktail (Roche, Indianapolis, IN) as
described before. The protein concentration of each
sample was determined using a BCA Protein Assay
Reagent (Pierce); 100–150mg of total protein was sub-
jected to 9–15% sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS–PAGE) and transferred to nitro-
cellulose membranes (Millipore). Immunodetection was
performed by incubating with primary antibodies [anti-
Lsh (sc-28202) (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA), p16
INK4a (Lab Vision & NeoMarkers,
CA, USA), phospho-Rb (Ser795) (Cell Signaling
Technology Inc., Danvers, MA, USA) and overnight at
48C, followed by rinses and addition of HRP-conjugated
secondary antibodies (Zhongshan, China). Incubation
with anti-b-actin (sc-1616) (Santa Cruz) or anti-tubulin
(ab7291) (Abcam, Cambridge, UK) served as a loading
control. Proteins were visualized using SuperSignal
WestPico Chemiluminescent Substrate (Pierce) according
to manufacturer’s instructions.
ChIP
Assays were performed using a ChIP assay kit (Upstate
Biotechnology, Lake Placid, NY) according to the manu-
facturer’s instructions with minor modiﬁcations. In brief,
normal or stably transfected 2BS cells at a density of
80–90% conﬂuency were used in ChIP assays with anti-
Lsh, anti-HDAC1 (sc-8410x) (Santa Cruz), anti-HDAC2
(sc-6296x) (Santa Cruz) and anti-acetylated Histone
H3(Upstate) antibodies. DNA isolated from the immuno-
precipitates were quantiﬁed by traditional PCR or real-
time PCR using a primer pair complementary to the p16
promoter, including a forward primer (F: 50-GAA AGA
TAC CGC GGT CCC TC-30) and a reverse primer
(R: 50-ACC GTA ACT ATT CGG TGC GTT GG-30),
which amplify the region between nucleotides  177 and
+135 within the p16 promoter region (19) that correlates
with loss of gene expression. As an internal control, a
region upstream of the p16 promoter was ampliﬁed
using a forward primer (control-F: 50-CCC TTC CCC
CCT TAT AAT TAC G-30) and a reverse primer (con-
trol-R: 50-GGA CGG ACT CCA TTC TCA AAG-30)
(20). Input DNA as well as DNA immunoprecipitated
by anti-actin or IgG served as positive or negative control,
respectively. Re-ChIP was performed as described
previously (21).
Real-time PCR and data analysis
Two-step real-time PCR was performed with 5ml of DNA
and 400nM primers diluted to a ﬁnal volume of 50ml
in SYBR Green Master Mix (Applied Biosystems).
Accumulation of ﬂuorescent products was monitored by
real-time PCR using an Applied Biosystem 7300 real-time
PCR system (Applied Biosystems). A melting curve was
generated to ensure that a single peak of the predicted Tm
was produced and no primer-dimer complexes were
present. Single amplicon generation was veriﬁed by agar-
ose gel electrophoresis. No PCR products were observed
in the absence of template. Sequence Detector software
(version 1.3.1) was used for data analysis and relative
fold induction was determined by the comparative
threshold cycle (CT). Fold enrichments were determined
by the method described in the Applied Biosystems User
Bulletin and data analysis followed the methodology
described in a recent report (22). Fold diﬀerences were
calculated by correcting for each signal concentration
with the concentration of input signal for each sample
[(signal concentration)/(input concentration)]. Real-time
PCR data ﬁgures were generated using Microsoft Excel
(Microsoft Corporation, USA).
For real-time RT–PCR in Figures 3D and Figure 6B,
the primers speciﬁc for p16 gene were used as described
previously (Primer R, 23). The relative abundance of p16
mRNA levels was calculated after normalization using
GAPDH mRNA levels as the internal control.
Coimmunoprecipitation assays
For coimmunoprecipitation experiments, normal 2BS cells
or Lsh-HA-overexpressing 2BS cells were collected from a
10-cm-diameter plate using RIPA buﬀer containing pro-
tease inhibitor cocktail (Roche). Lysates were precleared
by incubation with 100ml of protein G-Sepharose (50%
slurry) for 1h. The cleared lysate was then subjected to
immunoprecipitation with the indicated antibodies over-
night at 48C. Protein G-Sepharose beads (Sigma) were
added and the incubation was continued for 2h at 48C.
Precipitates were washed four times with RIPA buﬀer
(1ml), followed by resuspension in 2 SDS loading
buﬀer. Proteins were separated using gradient SDS–
PAGE gels (7.5–10%), followed by electrophoretic trans-
fer to Immobilon-P membranes (Millipore). Endogenous
Lsh protein was immunoprecipitated or immunoblotted
using rabbit anti-Lsh antibodies. Blots were also probed
with anti-HA, anti-HDAC1 and anti-HDAC2 antibodies
overnight at 48C, followed by HRP-conjugated secondary
antibodies for 1h at room temperature. All coimmunopre-
cipitation experiments included normal immunoglobulin
(Ig) as a negative control.
GST pull-down assays
For pull-down experiments, Escherichia coli strain DH5a
was used to produce GST or GST fusion protein.
In vitro transcripted/translated HDAC1 using TNT T7
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used as a source of puriﬁed HDAC1 protein. GST pull-
downs were performed as described previously (24).
In brief,  5mg of GST or GST-Lsh bacterial recombinant
protein immobilized on glutathione–Sepharose 4B resin
was pre-blocked with 1% bovine serum albumin and
then incubated with the puriﬁed HDAC1 protein for 4h
on a rotator at 48C. After an extensive wash with lysis
buﬀer, the bound proteins were fractionated by SDS–
PAGE and subjected to western blot analysis with anti-
HDAC1 antibody.
Methylation-specific PCR (MSP)
DNA was extracted and treated with bisulﬁte, as described
previously with minor modiﬁcations (25). Brieﬂy, genomic
DNA (1mg) in a volume of 50ml was denatured by NaOH
(ﬁnal concentration, 0.275M) for 10min at 428C. The
denatured DNA was then treated with 10mlo f1 0 m M
hydroquinone and 520ml of 3M sodium bisulﬁte at 508C
overnight, followed by puriﬁcation using a QiaQuick
DNA puriﬁcation kit (QIAGEN). Primer sequences and
PCR conditions were described previously for the p16
gene [Primer L&N, (23)]. Primers were localized to regions
in and around the transcription start site of the p16 gene, a
region that correlates with loss of gene expression. The
genomic DNA treated with in vitro methylation was
used as positive control. The in vitro methylation was
carried out as previously described (26). SssI methylase
and S-adenosylmethionine were purchased from New
England Biolabs.
RESULTS
Lsh overexpression delays cell senescence, whereas
shRNA-mediated Lsh silencing leads to a cell-cycle arrest,
SAHF and premature senescence in human fibroblasts
The senescent state of normal human diploid ﬁbroblast
cells is characterized by irreversible growth arrest and
morphologically enlarged, ﬂattened cells with prominent
lipofuscin granules and irreversible growth arrest (27).
To determine the eﬀects of Lsh expression levels on cellu-
lar senescence, we overexpressed Lsh by Lsh–HA or
silenced Lsh by Lsh-shRNA in young 2BS cells. To deter-
mine whether the eﬀect of Lsh-shRNA on senescence
truly depend on the depletion of Lsh, we performed
rescue experiment by introducing exogenous Lsh in Lsh–
shRNA-expressing 2BS cells (Supplementary Figure 3S).
After sustained selection with G418, the transformants
were obtained. The transfection eﬃciencies of Lsh-HA
or Lsh–shRNA were conﬁrmed by immunoblot analysis
(Figure 1). The senescence markers for Lsh-shRNA-
expressing cells or Lsh-HA-overexpressing cells were
monitored at the same time points as their corresponding
negative control cells (Figure 2). To determine whether the
eﬀects associated with altered Lsh expression levels are a
general accompaniment to senescence, we extended our
study to investigate additional normal human diploid
ﬁbroblast WI-38 cells.
Lsh delays a senescence-like cell morphology and inhibits
SA-b-Gal activity
We monitored cell morphological changes in cells with
altered Lsh expression. The Lsh-shRNA-infected 2BS
cells (PD 42) showed increasing gross enlargement, ﬂatten-
ing and the accumulation of granular cytoplasmic inclu-
sions. However, no signiﬁcant morphological changes
were observed in Lsh-HA-transfected cells (PD 55),
which retained a refractive cytoplasm with thin, long pro-
jections similar to young control cells (Figure 2A and B).
The speciﬁc senescence-associated marker, pH 6.0 opti-
mum b-galactosidase (SA-b-gal), was assayed by X-gal
staining. Whereas nearly all of the Lsh–shRNA-infected
cells (PD 42) showed strong levels of blue SA-b-gal stain-
ing similar to senescent cells, the control cells showed a
lower frequency of SA-b-gal staining (Figure 2B).
However, only sporadic SA-b-gal-positive cells were
seen in Lsh-HA-transfected cells (PD 55), although the
corresponding vector control cells (PD 55) showed
strong SA-b-gal staining (Figure 2A). We obtained similar
results using WI-38 cells (Figure 2C).
Lsh blocks the formation of senescence-associated
heterochromatin foci (SAHF)
The accumulation of senescence-associated heterochroma-
tin foci (SAHF) is another speciﬁc biomarker of senescent
cells (28). As shown in Figure 2A and B, senescence
induced by extensive passage culture typically displayed
punctuated DNA foci which were visualized by DAPI
staining. In contrast, exponentially growing human ﬁbro-
blasts usually displayed several small nucleoli and a
more uniform DAPI-staining pattern. We observed that
2BS cells expressing Lsh–HA (PD 55) did not develop
pronounced nucleoli or DNA foci when vector-transfected
cells (PD 55) appeared prominent DNA foci (Figure 2A).
A
B
WI-38 cells
vector      Lsh-HA
Lsh
vector     Lsh-HA control    Lsh-shRNA
2BS cells  2BS cells 
Lsh Lsh
β-actin β-actin
β-actin
Figure 1. Immunoblot analyses of Lsh expression levels in Lsh-HA-
transfected or Lsh-shRNA-infected cells. (A) Immunoblot analysis of
Lsh protein levels in 2BS cells exposed to Lsh-HA or Lsh-shRNA as
well as the corresponding control. The vector- or Lsh-HA-transfected
cells were analyzed at 55 PD using 100mg of total protein. The control-
or Lsh-shRNA-infected cells were analyzed at 42 PD using 120mgo f
total protein. (B) Immunoblot analysis of Lsh protein levels in WI-38
cells exposed to vector or Lsh-HA. The vector- or Lsh-HA-transfected
cells were analyzed at 37 PD using 100mg of total protein.
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D
Vector (55PD)
2BS cells 
B
C
Vector (37PD)
WI-38 cells 
Control (42PD)
2BS cells 
Senescent (60PD)  Lsh-HA (55PD) Young (24PD)
Senescent (60PD) Lsh-shRNA (42PD) Young (24PD)
Lsh-HA (37PD) 
Figure 2. Lsh overexpression suppresses senescence-associated features in 2BS and WI-38 cells. The stable transformants were passaged until one of
them underwent senescence and analyzed for the relative senescence markers (vector- or Lsh-HA-transfected 2BS cells at PD 55, vector- or Lsh-HA-
transfected WI-38 cells at PD 37, control-shRNA- or Lsh-shRNA-infected 2BS cells at PD 42). (A) Vector-transfected and Lsh-HA-transfected 2BS
cells were stained for SA-b-gal activity (upper panel) or SAHF formation (middle and lower panels, 20mmo r8 mm bars respectively). (B) Control-
shRNA-infected and Lsh-shRNA-infected 2BS cells were stained for SA-b-gal activity (upper panel) or SAHF formation (middle and lower panels,
20mmo r8 mm bars respectively). Young (24 PD) and senescent (60 PD) 2BS cells were stained as normal controls. (C) Vector-transfected and
Lsh-HA-transfected WI-38 cells were stained for SA-b-gal activity. (D) Cell growth assay performed in 2BS cells by MTT method. (E) Cell-cycle
proﬁle analysis by ﬂow cytometry.
Nucleic Acids Research, 2009,Vol.37, No. 15 5187When Lsh-shRNA-infected cells (PD 42) appeared prom-
inent DNA foci which are nearly indistinguishable
from those in senescent 2BS cells, the control-shRNA
cells (PD 42) displayed a more uniform DAPI-staining
pattern (Figure 2B). Taken together, these results were
consistent with our previous studies showing senescent
SA-b-gal staining.
Lsh overexpression promotes cell growth, whereas
shRNA-mediated silencing of Lsh expression leads to
growth inhibition
The proliferative capacity of cells declines signiﬁcantly as
they enter senescence. To determine the eﬀect of Lsh
expression levels on proliferative changes, the growth
rates of various transformants were measured using
MTT assays. The results revealed that growth of Lsh-
HA-transfected cells advanced quickly, suggesting a
strong proliferative potential relative to the control cells
(Figure 2D). However, when Lsh expression was inhibited
by shRNA targeting, 2BS cells showed severe growth
retardation (Figure 2D).
Lsh overexpression alleviates G1 cell-cycle arrest
To deﬁne further the mechanisms underlying growth rate
promotion by Lsh, the cell-cycle proﬁles of various trans-
formants were analyzed by ﬂow cytometry. Whereas
vector-transfected cells entered the irreversible G1 arrest,
Lsh-HA-transfected cells exhibited a signiﬁcantly post-
poned irreversible growth arrest (Figure 2E). In contrast
to the severe G1 cell-cycle arrest imposed by Lsh-shRNA,
the control-shRNA cells showed a decrease in the propor-
tion of 2BS cells in the G0/G1 phases (Figure 2E).
Therefore, Lsh may promote cell proliferation by stimu-
lating cell-cycle progression.
Lsh overexpression results in a finite extension of
fibroblast replicative lifespan
The replicative senescence of normal human diploid
ﬁbroblasts is directly correlated to their PD number,
rather than to their growth and metabolic time (1,29).
After completing a ﬁnite number of divisions, cells enter
a permanent growth arrest. To determine the eﬀect of Lsh
expression levels on the lifespan of 2BS cells, the number
of PDs for Lsh-HA-transfected cells, Lsh-shRNA-infected
cells and the corresponding control cells from the same
set of early passage cells were counted. The lifespan of
Lsh-HA cells (PD 65–70) was about 10–12 PDs greater
than the vector control 2BS cells (PD 55–58) (Table 1).
In contrast, Lsh-shRNA cells (PD 42–45) ceased cell divi-
sion at 13 PDs earlier than the control-shRNA cells (PD
55–58), remaining in the sub-conﬂuent stage even after
two months under normal culture conditions (Table 2).
Lsh represses endogenous p16
INK4a expression
Senescence is the ﬁnal phenotypic state in response to
various physiologic types of stress resulting in decreased
cell proliferation and often mediated by increased expres-
sion and activation of tumor suppressor genes such as
p16
INK4a, p53 and p21 (30,31). Prominent among these
is p16
INK4a (30). Previous reported that PASG mutant
mice demonstrate a markedly increased expression of
p16
INK4a. Therefore, we hypothesized that p16 is a Lsh
target gene. First, we determined whether Lsh overexpres-
sion could downregulate p16 protein expression. As
shown in Figure 3A, the expression of p16
INK4a was sig-
niﬁcantly repressed in Lsh-HA-transfected 2BS cells com-
paring to vector-transfected cells. As a direct target of p16,
Rb phosphorylation increased. Furthermore, we also
observed Lsh-mediated repression of p16 in HeLa cells
and in WI-38 cells (Figure 3B).
To further explore the role of Lsh-mediated p16 repres-
sion, we silenced the Lsh gene using shRNA and examined
p16 expression levels in 2BS cells. Immunoblot analysis
revealed a marked increase in p16
INK4a protein levels in
Lsh-shRNA cells comparing to control-shRNA cells
(Figure 3C). Moreover, quantitative RT-PCR analysis of
Lsh-shRNA-infected cells showed a signiﬁcant increase in
p16 mRNA levels in 2BS cells (Figure 3D), suggesting that
Lsh may normally regulate p16 transcription. Collectively,
these results suggest that p16
INK4a may play a key-regula-
tory role in Lsh-mediated cell senescence.
Lsh expression inversely correlates with p16
INK4a expression
in young and senescent cells
Due to the eﬀect of Lsh on cell senescence and the role of
Lsh in the modulation of p16
INK4a expression, we further
evaluated the expression patterns of Lsh and p16
INK4a in
young and senescent 2BS or WI-38 cells. Immunoblot
analyses revealed that the levels of Lsh were signiﬁcantly
decreased in senescent cells compared to young cells
(Figure 4A and B, upper panels). As expected, young
cells possessed low p16
INK4a levels. However, there was
an increase in the p16
INK4a level in senescent cells
(Figure 4A and B, middle panels). These data indicated
that young cells expressed high level of Lsh, however,
Lsh expression declined accompanied by improving
level of p16
INK4a and the onset of cellular senescence.
Table 1. Cumulative population doublings of vector- or Lsh-HA-
transfected 2BS cells
Cells No. of
examples
Cumulative population
doublings
Vector 6 55–58
Lsh-HA 8 65–70
Untransfected cells 5 55–60
Table 2. Cumulative population doublings of control-shRNA- or Lsh-
shRNA-infected 2BS cells
Cells No. of
examples
Cumulative population
doublings
Control-shRNA 6 55–58
Lsh-shRNA 6 42–45
Untransfected cells 5 55–60
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senescence and inversely correlated with p16
INK4a, which
gave the opportunity for Lsh to adjust p16
INK4a expres-
sion through the change of itself.
Silencing of p16 rescues Lsh shRNA-induced premature
senescence in 2BS cells
In order to further verify that Lsh could regulate
senescence via p16
INK4a, we evaluated the role of p16 in
mediating the senescence eﬀects of Lsh-shRNA in 2BS
cells. Young 2BS cells infected with both Lsh-shRNA
and p16-shRNA or with Lsh-shRNA or p16-shRNA
alone were monitored. The results showed that cells trea-
ted with Lsh-shRNA alone revealed strong SA-b-gal
staining, severe growth retardation and signiﬁcant p16
increasing, whereas cells doubly treated with Lsh-
shRNA and p16-shRNA completely reversed the senes-
cence phenotypes. As expected, p16-shRNA-infected
cells displayed young phenotypes (Figure 5). Importantly,
the p16 shRNA reagent did not overtly compromise the
A
B
C
control
2BS cells 
p16 
vector
Hela cells  WI-38 cells 
vector
p16  p16  
vector
2BS cells 
p16  
pRb  
β-actin  
β-actin   β-actin
β-actin
Lsh-HA
Lsh-HA
Lsh-shRNA
Lsh-HA
D
I.
II.
Figure 3. Lsh represses endogenous p16 levels. (A) Immunoblot analy-
sis of expression levels of p16 and phosphorylation levels of Rb in 2BS
cells exposed to empty vector or Lsh-HA. (B) Immunoblot analysis of
p16 expression levels in Hela cells or WI-38 cells, exposed to empty
vector or Lsh-HA. (C) Immunoblot analysis of p16 levels in 2BS cells
exposed to control-shRNA or Lsh-shRNA. (D) Quantitative RT–PCR
measuring p16 mRNA levels in 2BS exposed to control-shRNA or Lsh-
shRNA. Non-normalized GAPDH and p16 mRNA levels are presented
in graph I. (Graph II) After normalization against GAPDH mRNA,
the relative p16 mRNA abundance was calculated. The data presented
are average values obtained from triplicate points from a representative
experiment (n=3), which was repeated three times with similar results.
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Figure 4. The expression patterns of Lsh and p16
INK4a in young and
senescent cells. Immunoblot analysis of Lsh and p16
INK4a expression in
young and senescent 2BS cells (A) or WI-38 cells (B). Total proteins
were extracted, and immunoblotting was performed using speciﬁc anti-
bodies against Lsh and p16
INK4a as indicated. The b-actin lane serves
as a loading control.
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cells doubly infected with viruses encoding shRNAs for
p16 and Lsh (Figure 5A, lower panel).
Lsh-mediated p16 repression requires HDAC activity,
but does not DNMT activity
It has been suggested that histone deacetylation and
DNA methylation could participate in gene repression
mediated by some members of SNF family (32–34).
Thus, we decided to investigate whether Lsh-mediated
p16 repression requires HDAC or DNMT activity.
First, we tested the ability of TSA, a speciﬁc inhibitor
of HDAC activity, to overcome the Lsh-mediated repres-
sion of p16. Immunoblot analysis of p16 protein levels
indicated that the repression of p16 expression by Lsh
was reversed to near completion by the addition of low
levels (10ng/ml) TSA in 2BS cells (Figure 6Ai). However,
TSA did not alter the endogenous Lsh expression levels
(Figure 6Aii). We further quantiﬁed the p16 mRNA levels
using quantitative RT–PCR, and veriﬁed the ability of
TSA to overcome the Lsh-mediated p16 repression
(Figure 6B). These results suggest that repression of p16
Lsh-mediated may depend on HDAC activity.
To verify this notion, we further determined whether
Lsh expression correlated with histone deacetylation at
the p16 promoter. To address this point, we ﬁrst analyzed
the acetylation status of histone H3 at the p16 promoter in
Lsh-HA-transfected cells or in vector-transfected cells.
ChIP analysis revealed that Lsh overexpression was asso-
ciated with a signiﬁcant decrease in the levels of acetylated
histone H3 at the p16 promoter (Figure 6C). If TSA treat-
ment directly aﬀects p16 gene expression levels, one would
expect to observe the eﬀect of TSA on the histone acetyla-
tion status at the p16 promoter. The results showed
that TSA treatment led to a strong increase in histone
acetylation levels at the p16 promoter whether in Lsh-
HA-transfected cells or in vector-transfected cells, which
could completely reverse the p16 promoter deacetylation
induced by Lsh-HA overexpressing (Figure 6C).
Quantitative real-time PCR analyses were performed to
verify the ChIP measurements (Figure 6D).
To further conﬁrm that Lsh expression correlates
with the deacetylation status of the p16 promoter, we per-
formed ChIP assays in Lsh-shRNA- or control-shRNA-
infected 2BS cells. Consistent with our previous point, the
results showed that knockdown of Lsh resulted in a strong
increase in the levels of histone H3 acetylation at the
p16 promoter (Figure 6E). Quantitative real-time PCR
analyses further veriﬁed the increasing (Figure 6F).
Next, we analyzed the eﬀect of 50-aza-CdR, which spe-
ciﬁcally inhibits DNMTs, in the Lsh-mediated repression
of p16. Immunoblot analyses showed that the addition of
50-aza-CdR didn’t alter the repression status of p16 by Lsh
(Figure 7A); suggesting that Lsh-mediated repression of
p16 doesn’t depend on DNMT activity.
To further conﬁrm this notion, we examined whether
Lsh expression correlates with CpG methylation at the
p16 promoter. We then monitored the CpG-methylation
status of the p16 promoter in Lsh-HA-transfected cells
or in vector-transfected cells using methylation-speciﬁc
PCR method. The results showed no detectable p16
methylation whether in Lsh-HA-transfected cells or in
vector-transfected cells (Figure 7B), which further verify
that Lsh-mediated repression of p16 doesn’t depend on
DNMT activity.
Lsh associates with HDAC1 and HDAC2 in vivo
To gain further insights into the mode of Lsh-mediated
repression, we analyzed the association between speciﬁc
HDACs and Lsh. In the present study, we determined
the interaction between endogenous Lsh and the class I
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Figure 5. The silencing of p16
INK4a rescues Lsh-shRNA-mediated pre-
mature senescence in 2BS cells. (A) Immunoblot analysis of the p16 or
Lsh protein levels in 2BS cells exposed to the indicated perturbations.
The Tubulin lane serves as a loading control. (B) Senescent b-gal stain-
ing in 2BS cells exposed to the indicated perturbations. (C) Cell growth
assay performed in 2BS cells by MTT method.
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cells. As shown in Figure 8A upper panel, the immuno-
precipitate of Lsh associates with endogenous HDAC1,
as detected by immunoblot. The reverse coimmunopreci-
pitation experiments were also preformed to conﬁrm
this association. We immunoprecipitated HDAC1 and
HDAC2 from cell extracts, and used an anti-Lsh antibody
to detect bound Lsh, thereby providing evidence for an
in vivo association between Lsh and HDAC1/HDAC2
(Figure 8A, lower panel).
To further conﬁrm this interaction in vivo, we then
monitored the association of Lsh and HDAC1 in siLsh-
transfected Hela cells relative to mock-transfected cells.
The results showed that Lsh immunoprecipitates from
Lsh-deﬁcient cells contained signiﬁcantly decreased
HDAC1 levels relative the mock-transfected cells;
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Figure 6. Lsh-mediated p16 repression requires HDAC activity. (A) (i)
Immunoblot analysis of the p16 protein levels in vector- and Lsh-HA-
transfected 2BS cells with or without TSA treatment. (ii) Immunoblot
analysis of the Lsh protein levels in normal 2BS cells opposed to TSA.
(B) Quantitative RT-PCR measuring p16 mRNA levels in vector- and
Lsh-HA-transfected 2BS cells with or without TSA treatment. (C) ChIP
analysis of histone H3 acetylation status at the endogenous p16 pro-
moter in vector- and Lsh-HA-transfected 2BS cells with or without
TSA treatment. ChIP assays were quantiﬁed by real-time PCR (D).
(E) ChIP analysis of the histone H3 acetylation status at the endogen-
ous p16 promoter in control shRNA- and Lsh-shRNA-infected 2BS
cells. ChIP assays were quantiﬁed by real-time PCR (F).
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result (Figure 8B).
In addition, GST pull-down experiments with bacteria-
expressed GST-Lsh and in vitro transcripted/translated
HDAC1 were then performed to examine the nature of
the interaction between Lsh and HDAC1. These experi-
ments revealed that Lsh could interact with HDAC1
indirectly (Figure 8C).
Lsh, HDAC1 and HDAC2 interact with the p16
promoter
To determine whether Lsh and its associated proteins
exert functions by direct recruitment to p16 promoter,
we performed a series of ChIP assays in 2BS cells.
The results showed that anti-Lsh, anti-HDAC1 and anti-
HDAC2 antibodies all immunoprecipitated the p16 pro-
moter region (Figure 9A). Very little ampliﬁcation was
observed when control primers were used to amplify the
immunoprecipitated DNA (Figure 9A, bottom panels).
To further ensure the colocalization of Lsh with
HDAC1, Re-ChIP was performed using an anti-Lsh anti-
body, followed by reimmunoprecipitation using an anti-
HDAC1 antibody, and the detection of PCR-ampliﬁed
signal in the p16 promoter region. The results showed
that both Lsh and HDAC1 associate with the regulatory
region of the p16 promoter (Figure 9B).
We next investigated whether Lsh mediates the recruit-
ment of HDAC1 to the p16 promoter. ChIP analyses
revealed that anti-HDAC1 antibodies immunoprecipi-
tated higher amounts of the p16 promoter region in Lsh-
HA-overexpressing cells relative to the vector control cells.
Conversely, when Lsh expression was inhibited using
shRNA, the recruitment of HDAC1 to the p16 promoter
was signiﬁcantly impaired (Figure 9C). Quantitative
real-time PCR veriﬁed the recruitment (Figure 9D).
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Figure 8. Lsh associates with HDAC1 and HDAC2. (A) Coimmuno-
precipitation of Lsh with HDAC1 and HDAC2 in 2BS cells. Cell
lysates from normal 2BS cells were subjected to immunoprecipitation
using anti-Lsh, anti-HDAC1 or anti-HDAC2 antibodies. The immuno-
precipitated complexes were separated by SDS–PAGE and subjected to
immunoblot analysis using the indicated antibodies. (B) Coimmunopre-
cipitation analysis of Lsh with HDAC1 in Lsh-deﬁcient Hela cells. Hela
cells were transiently transfected with pSilencer vector or with pSilen-
cer-siLsh. Cells were harvested at 48h post-transfection. Cell extracts
were immunoprecipitated with anti-Lsh or anti-HDAC1 antibodies as
indicate, and analyzed by western blotting with anti-HDAC1 or anti-
Lsh antibodies. (C) In vitro GST-binding assay for interaction between
GST-Lsh and HDAC1. GST alone or GST-fusion protein GST-Lsh
immobilized on glutathione–Sepharose 4B resin were incubated with
puriﬁed HDAC1 protein generated by in vitro transcription/translation
system. The bound fractions from the glutathione–Sepharose beads and
the input cell extract were analyzed by western blotting with anti-
HDAC1 antibodies (upper panel). Analysis of the GST alone or GST
fusion proteins used is shown in the lower panel.
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Aging can be deﬁned as progressive functional decline and
increasing mortality over time. Previous studies have
demonstrated that targeted deletion of Lsh in mice leads
to developmental growth retardation and premature
aging phenotypes (6). Moreover, PASG mutant mice
display a signiﬁcant increase in the expression of
senescence-related genes, including p16
INK4a, p19
ARF,
p53 and p21 (6). However, the function of Lsh in human
cellular senescence has never been described. In the present
study, we showed that Lsh delayed cellular senescence in
human ﬁbroblasts (Figure 2), an eﬀect attributed to the
repression of p16
INK4a (Figure 3), which is an important
cell-cycle inhibitor, and its accumulation triggers the onset
of cellular senescence (35). However, a recent publication
draws some diﬀerent conclusions (36). We think the diﬀer-
ent ﬁndings were due to the diﬀerent cell lines. TIG-7 cell is
a human fetal diploid cell strain; while 2BS cell is a human
embryo diploid cell strain, which stay at earlier develop-
mental stage. It may be the key cause of the diﬀerent ﬁnd-
ings between two cell lines upon to PASG knockdown.
Secondly the original gender is diﬀerent. The former
comes from male and the latter comes from female.
2BS cells were previously isolated from human fetal
lung ﬁbroblast tissue and have been fully characterized
(14). The maximum population doubling of human
diploid ﬁbroblasts is limited in culture, so they are
widely used as a model of cellular senescence. Previous
reports have suggested that ﬁbroblast cellular senescence
occurs as a consequence of a ‘genetic program’ (37).
This program has been partially characterized by gene
expression patterns during the progression of successive
passages, such as, the upregulation of senescence-asso-
ciated tumor suppressor, p16
INK4a. Here, we found that
overexpression of Lsh markedly inhibited p16
INK4a
expression (Figure 3A and B). Moreover, the shRNA-
mediated silencing of Lsh led to an upregulation of
p16
INK4a levels (Figure 3C and 3D). Therefore, we con-
cluded that Lsh could repress the endogenous p16
INK4a.
In addition, we detected the endogenous expression pat-
terns of Lsh and p16
INK4a in young and senescent 2BS
cells or WI-38 cells (Figure 4A and B), establishing a rela-
tionship between p16
INK4a and Lsh expression and a cor-
relation between Lsh expression and the age of cells. Lsh
expression levels signiﬁcantly declined in senescent ﬁbro-
blasts, which inversely correlated with p16
INK4a expres-
sion, thereby allowing changes in Lsh expression to
regulate p16
INK4a expression.
Since Lsh repressed endogenous p16 expression and
delayed cellular senescence in 2BS cells, we next asked
whether p16 is required for Lsh-regulated senescence.
Experiments in Figure 5 showed that p16 deletion could
completely rescue the senescent eﬀect and the upregulation
of p16 by Lsh-shRNA, suggesting that the p16/Rb path-
way is required for Lsh-shRNA-induced premature
senescence.
Lsh, a member of the SNF2 family of chromatin remo-
deling proteins, is an epigenetic regulator in mice
(3,11,12,38). SNF2-like proteins are classiﬁed into three
subfamilies according to the similarity of their ATPase
catalytic domain to either yeast SWI2/SNF2, mammalian
Mi-2/CHD or Drosophila ISWI (39). Chromatin remodel-
ing can be targeted to promoters or other speciﬁc regions
of the genome (40,41). More recent genome-wide studies
have revealed that several SNF2 family members can func-
tion both as positive and negative regulators of gene
expression, possibly by altering chromatin modiﬁcation
(41,42). For example, Fan et al. (2005) found that Lsh
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Figure 9. Lsh interacts with the endogenous p16 promoter and recruits
HDAC1 in 2BS cells. (A) ChIP analysis of the p16 promoter using the
indicated antibodies. (B) Re-ChIP analysis showing the colocalization
of Lsh with HDAC1at the p16 promoter. (C) HDAC1 recruitment
analysis at the endogenous p16 promoter in Lsh-expressing cells or
Lsh-deﬁcient 2BS cells. Quantitative real-time PCR veriﬁed the recruit-
ment (D).
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gene by a direct association with the 50 DMR and alter-
ation of the CpG methylation at the Cdkn1c promoter
(34). However, the induction of p16
INK4a by Lsh mutant
was not related to promoter demethylation (6). Consistent
with this ﬁnding, we found that Lsh overexpression did
not alter the CpG methylation of the p16 promoter
(Figure 7B) and Lsh-mediated repression of p16 was inde-
pendent of DNMT activity (Figure 7A).
Covalent modiﬁcation of the N-terminal tails of
chromatin core histone proteins, including acetylation,
phosphorylation and methylation, often correlates
with transcriptional events, which is to be essential for
proper gene expression. Acetylation of histones H3 and
H4 relieves structural chromatin compaction, possibly
through disruption of interactions between adjacent
nucleosomes or by loosening contacts between histones
and DNA. It has been reported respectively that INI1/
hSNF5, another SWI/SNF family member, represses
cyclin D1 and c-fos transcription by inducing Histone
H4 deacetylation of the promoter (32,33). Moreover, sev-
eral previous studies have reported that HDAC inhibitor
can induce p16 expression (43–45). In the search for the
molecular mechanisms involved in the regulation of p16
by Lsh, overexpression of Lsh was found to induce the
deacetylation of histone H3 on the p16 promoter in vivo,
which can be reversed by treatment with the speciﬁc
HDACs inhibitor, TSA (Figure 6C and D). Consistent
with the ﬁndings, both immunoblot and quantitative
RT-PCR analysis revealed that Lsh-mediated repression
of endogenous p16
INK4a could be reversed by low concen-
trations of TSA (Figure 6A and B). Therefore, for the ﬁrst
time, we reported that histone deacetylation by HDACs
may participate in the regulation of p16 by Lsh.
HDACs are frequently recruited to speciﬁc DNA
sites through association with corepressor molecules.
Moreover, the silencing of tumor suppressor genes
through the aberrant targeting of HDACs to their gene
promoters may be more common than previously realized.
Therefore, we hypothesized that Lsh could recruit
HDACs to the p16 promoter, resulting in the propagation
of a repressive chromatin state. Coimmunoprecipitation
assays veriﬁed the association of Lsh with HDAC1 and
HDAC2 in vivo (Figure 8A and B). However, GST-Pull
down assays demonstrated that the interaction between
Lsh and HDAC1 could be indirect (Figure 8C).
How does Lsh as well as the associated proteins exert
the ability to silence p16
INK4a? We ﬁrst hypothesized that
Lsh could be targeted to the p16 promoter. ChIP assays
indicated that Lsh, HDAC1 and HDAC2 bound the
proximal region of the p16 promoter in vivo (Figure 9A).
We further performed Re-ChIP assays to verify the colo-
calization of Lsh with HDAC1 at the p16 promoter
(Figure 9B). Quantitative analysis of HDAC1 binding
to the p16 promoter showed that Lsh overexpression
increased the amounts of HDAC1 binding at the p16
promoter, whereas Lsh knockdown blocked this binding
(Figure 9C and D), suggesting that Lsh may recruit
HDAC1 to the p16 promoter. In conclusion, Lsh may
induce the deacetylation of histone H3 by recruiting
HDAC1 to the p16 promoter. These ﬁndings elicit
speculation about mechanisms that Lsh may regulate
p16 silencing (Figure 10).
It is well known that p16
INK4a is an important cell-cycle
inhibitor which can induce senescence and repress tumor
cell growth (46). Its loss or inactivation is correlated
with cell immortality (47). Although p16
INK4a plays an
important role in cellular senescence and tumorigenesis,
its transcriptional control is poorly understood. Here, we
report, for the ﬁrst time to our knowledge, the molecular
mechanism by which Lsh regulates the expression of
p16
INK4a in 2BS cells. However, recent studies have pro-
posed p16-regulatory pathways that are distinct from
those described here. Jacobs et al. reported that the
oncogene and polycomb-group gene bmi-1 regulates cell
proliferation and senescence through the ink4a locus (48).
Ohtani et al. proposed a model in which the upregulation
of p16
INK4a depended on the accumulation of Ets1 and
the absence of interference by Id1 during senescence (49).
Zheng et al. found that Id1 regulated p16
INK4a levels
through interactions with E47 (50). Wang et al. reported
that a 24-kDa protein might inhibit the expression of
p16
INK4a by interacting with the INK4a transcription
silence element (ITSE) (51). Recently, Gan et al. reported
that PPAR-gamma promotes cellular senescence by
inducing p16
INK4a expression (52); subsequently, Huang
et al. found that SIRT1 antagonizes cellular senescence
by reducing the expression of p16
INK4a and promoting
phosphorylation of Rb (53). These ﬁndings do not contra-
dict the present conclusions. It is clear that the p16 pro-
moter is subject to multiple levels of control (48,54);
therefore, p16 regulation cannot be explained by a single
isolated pathway.
In summary, Lsh is one of the critical factors involved
in the regulation of cell senescence. We conclude that the
high Lsh expression in young cells represses p16
INK4a
expression, thereby maintaining the proliferative state
of 2BS cells. Loss of Lsh expression may lead to increased
p16
INK4a expression in senescent 2BS cells, which in
turn contributes to the onset of cellular senescence.
Furthermore, we investigated the molecular mechanism
involved Lsh-mediated p16 repression, and established a
relationship between chromatin remodeling, gene repres-
sion and cell senescence. Future studies will be required to
determine the role played by the sequence-speciﬁc binding
factors to mediate the repression of p16 by Lsh.
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Figure 10. A model showing how Lsh may regulate p16 silencing.
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